Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2009 by Ora Bio Ltd..
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Ora Bio Ltd.
ClinicalTrials.gov Identifier:
NCT00745511
First received: September 2, 2008
Last updated: June 7, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2010
  Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)